OA10845A - Nouveaux dérivés de l'érythromycine leur procédé de préparation et leur application comme médicaments - Google Patents
Nouveaux dérivés de l'érythromycine leur procédé de préparation et leur application comme médicaments Download PDFInfo
- Publication number
- OA10845A OA10845A OA9800150A OA9800150A OA10845A OA 10845 A OA10845 A OA 10845A OA 9800150 A OA9800150 A OA 9800150A OA 9800150 A OA9800150 A OA 9800150A OA 10845 A OA10845 A OA 10845A
- Authority
- OA
- OAPI
- Prior art keywords
- formula
- radical
- compounds
- methyl
- dideoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9602472A FR2745290B1 (fr) | 1996-02-28 | 1996-02-28 | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA10845A true OA10845A (fr) | 2003-02-05 |
Family
ID=9489659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA9800150A OA10845A (fr) | 1996-02-28 | 1998-08-28 | Nouveaux dérivés de l'érythromycine leur procédé de préparation et leur application comme médicaments |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6096714A (ko) |
| EP (1) | EP0885234B1 (ko) |
| JP (1) | JP4102440B2 (ko) |
| KR (1) | KR100486053B1 (ko) |
| CN (1) | CN1168734C (ko) |
| AP (1) | AP952A (ko) |
| AR (1) | AR005999A1 (ko) |
| AT (1) | ATE217633T1 (ko) |
| AU (1) | AU716204B2 (ko) |
| BG (1) | BG63207B1 (ko) |
| BR (1) | BR9707709B1 (ko) |
| CZ (1) | CZ293893B6 (ko) |
| DE (1) | DE69712610T2 (ko) |
| DK (1) | DK0885234T3 (ko) |
| EA (1) | EA001376B1 (ko) |
| EE (1) | EE9800265A (ko) |
| ES (1) | ES2176698T3 (ko) |
| FR (1) | FR2745290B1 (ko) |
| HU (1) | HU227567B1 (ko) |
| IL (1) | IL125622A (ko) |
| NO (1) | NO983955L (ko) |
| NZ (1) | NZ331600A (ko) |
| OA (1) | OA10845A (ko) |
| PL (1) | PL191736B1 (ko) |
| PT (1) | PT885234E (ko) |
| SK (1) | SK118498A3 (ko) |
| TR (1) | TR199801713T2 (ko) |
| UA (1) | UA58504C2 (ko) |
| WO (1) | WO1997031929A1 (ko) |
| YU (1) | YU37098A (ko) |
| ZA (1) | ZA971659B (ko) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004514643A (ja) * | 1997-10-29 | 2004-05-20 | 大正製薬株式会社 | エリスロマイシンａ誘導体 |
| AU9649598A (en) * | 1997-10-29 | 1999-05-17 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a, 11,12-carbamate derivatives |
| JP4573925B2 (ja) * | 1998-07-09 | 2010-11-04 | アベンティス・ファーマ・ソシエテ・アノニム | 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用 |
| FR2780977B1 (fr) * | 1998-07-09 | 2000-09-01 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| FR2792637B1 (fr) * | 1999-04-26 | 2001-06-01 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
| FR2781484B1 (fr) | 1998-07-21 | 2001-08-10 | Hoechst Marion Roussel Inc | Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments |
| BR9916969A (pt) | 1999-01-27 | 2001-11-06 | Pfizer Prod Inc | Antibióticos cetólidos |
| WO2000071557A1 (en) * | 1999-05-24 | 2000-11-30 | Pfizer Products Inc. | 13-methyl-erythromycin derivatives |
| WO2001010880A1 (fr) * | 1999-08-06 | 2001-02-15 | Taisho Pharmaceutical Co., Ltd. | Derives d'erythromycine a |
| AU6316400A (en) * | 1999-08-06 | 2001-03-05 | Taisho Pharmaceutical Co., Ltd. | Erythromycin a derivatives |
| WO2001010878A1 (fr) * | 1999-08-06 | 2001-02-15 | Taisho Pharmaceutical Co., Ltd. | Derives d'erythromycine a |
| EP1146051A3 (en) * | 2000-04-10 | 2001-10-31 | Pfizer Products Inc. | Erythromycin A derivatives |
| US20020115621A1 (en) * | 2000-08-07 | 2002-08-22 | Wei-Gu Su | Macrolide antibiotics |
| ITMI20021726A1 (it) | 2002-08-01 | 2004-02-02 | Zambon Spa | Macrolidi ad attivita' antiinfiammatoria. |
| CA2529817C (en) | 2003-03-10 | 2013-02-12 | Optimer Pharmaceuticals, Inc. | Novel antibacterial agents |
| WO2005007143A2 (en) * | 2003-07-14 | 2005-01-27 | The Board Of Trustees Of The University Of Illinois | Use of makrolides and ketolides for the treatment of tuberculosis |
| WO2007069264A2 (en) * | 2005-12-15 | 2007-06-21 | Alembic Limited | Reference standards for determining the purity of telithromycin and processes therefor |
| CN101917850B (zh) | 2007-10-25 | 2016-01-13 | 森普拉制药公司 | 大环内酯类抗菌剂的制备方法 |
| WO2010048599A1 (en) | 2008-10-24 | 2010-04-29 | Cempra Pharmaceuticals, Inc. | Methods for treating gastrointestinal diseases |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| JP5914335B2 (ja) | 2009-09-10 | 2016-05-11 | センプラ ファーマシューティカルズ，インコーポレイテッド | マラリア、結核、及びｍａｃ病の治療方法 |
| NZ602544A (en) | 2010-03-22 | 2014-11-28 | Cempra Pharmaceuticals Inc | Crystalline forms of a macrolide, and uses therefor |
| US9051346B2 (en) | 2010-05-20 | 2015-06-09 | Cempra Pharmaceuticals, Inc. | Process for preparing triazole-containing ketolide antibiotics |
| JP6042334B2 (ja) | 2010-09-10 | 2016-12-14 | センプラ ファーマシューティカルズ，インコーポレイテッド | 疾患治療のための水素結合形成フルオロケトライド |
| SG11201405895UA (en) | 2012-03-27 | 2014-10-30 | Cempra Pharmaceuticals Inc | Parenteral formulations for administering macrolide antibiotics |
| US9861616B2 (en) | 2013-03-14 | 2018-01-09 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| JP6675973B2 (ja) | 2013-03-15 | 2020-04-08 | センプラ ファーマシューティカルズ，インコーポレイテッド | マクロライド抗菌薬を調製するための集束的な方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US487411A (en) * | 1892-12-06 | Island | ||
| IL99995A (en) * | 1990-11-21 | 1997-11-20 | Roussel Uclaf | Erythromycin derivatives, their preparation and pharmaceutical compositions containing them |
| US5444031A (en) * | 1993-01-21 | 1995-08-22 | Calgon Carbon Corporation | Process for making catalytic carbon |
| FR2727969B1 (fr) * | 1994-12-09 | 1997-01-17 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
-
1996
- 1996-02-28 FR FR9602472A patent/FR2745290B1/fr not_active Expired - Lifetime
-
1997
- 1997-02-25 AR ARP970100760A patent/AR005999A1/es unknown
- 1997-02-26 ZA ZA9701659A patent/ZA971659B/xx unknown
- 1997-02-27 SK SK1184-98A patent/SK118498A3/sk unknown
- 1997-02-27 UA UA98095031A patent/UA58504C2/uk unknown
- 1997-02-27 WO PCT/FR1997/000351 patent/WO1997031929A1/fr active IP Right Grant
- 1997-02-27 US US09/125,959 patent/US6096714A/en not_active Ceased
- 1997-02-27 ES ES97907141T patent/ES2176698T3/es not_active Expired - Lifetime
- 1997-02-27 TR TR1998/01713T patent/TR199801713T2/xx unknown
- 1997-02-27 AT AT97907141T patent/ATE217633T1/de active
- 1997-02-27 NZ NZ331600A patent/NZ331600A/xx unknown
- 1997-02-27 EP EP97907141A patent/EP0885234B1/fr not_active Expired - Lifetime
- 1997-02-27 PL PL328608A patent/PL191736B1/pl unknown
- 1997-02-27 KR KR10-1998-0706733A patent/KR100486053B1/ko not_active IP Right Cessation
- 1997-02-27 PT PT97907141T patent/PT885234E/pt unknown
- 1997-02-27 JP JP53067197A patent/JP4102440B2/ja not_active Expired - Lifetime
- 1997-02-27 DE DE69712610T patent/DE69712610T2/de not_active Expired - Lifetime
- 1997-02-27 AU AU19298/97A patent/AU716204B2/en not_active Expired
- 1997-02-27 BR BRPI9707709-7A patent/BR9707709B1/pt not_active IP Right Cessation
- 1997-02-27 EA EA199800768A patent/EA001376B1/ru not_active IP Right Cessation
- 1997-02-27 IL IL12562297A patent/IL125622A/xx not_active IP Right Cessation
- 1997-02-27 HU HU9902576A patent/HU227567B1/hu unknown
- 1997-02-27 EE EE9800265A patent/EE9800265A/xx unknown
- 1997-02-27 AP APAP/P/1998/001318A patent/AP952A/en active
- 1997-02-27 DK DK97907141T patent/DK0885234T3/da active
- 1997-02-27 CN CNB971926255A patent/CN1168734C/zh not_active Expired - Lifetime
- 1997-02-27 CZ CZ19982587A patent/CZ293893B6/cs not_active IP Right Cessation
-
1998
- 1998-08-12 BG BG102691A patent/BG63207B1/bg unknown
- 1998-08-27 NO NO983955A patent/NO983955L/no not_active Application Discontinuation
- 1998-08-28 OA OA9800150A patent/OA10845A/fr unknown
- 1998-08-28 YU YU37098A patent/YU37098A/sh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA10845A (fr) | Nouveaux dérivés de l'érythromycine leur procédé de préparation et leur application comme médicaments | |
| EP0799833B1 (fr) | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments | |
| CA2102457C (fr) | Derives de l'erythromycine, leur procede de preparation, leur application comme medicaments | |
| FR2697524A1 (fr) | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. | |
| EP0716093B1 (fr) | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments | |
| EP1016669B1 (fr) | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments | |
| EP1004592B1 (fr) | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments | |
| EP0974598B1 (fr) | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments | |
| CA2118564C (fr) | Derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
| EP0931088B1 (fr) | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
| CA2273985C (fr) | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
| FR2754821A1 (fr) | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
| EP1000952B1 (fr) | Nouveaux dérivés 2-halogénés de 5-0-désosaminylérythronolide A, leur procédé de préparation et leur application comme médicaments | |
| FR2691464A1 (fr) | Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments. | |
| EP0946580B1 (fr) | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
| CA2338172C (fr) | Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments | |
| CA2247175C (fr) | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
| FR2792637A1 (fr) | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
| FR2707088A1 (fr) | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. | |
| FR2780977A1 (fr) | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
| FR2697523A1 (fr) | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |